|
Volumn 9, Issue 9, 2010, Pages 675-676
|
The antibiotics market
a
IQVIA
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIVIRUS AGENT;
CEFCAPENE PIVOXIL;
CEFTAROLINE;
CEFTOBIPROLE;
CEFTRIAXONE;
CEFUROXIME AXETIL;
CEPHALOSPORIN DERIVATIVE;
CETHROMYCIN;
DALBAVANCIN;
DAPTOMYCIN;
FIDAXOMICIN;
ICLAPRIM;
LEVOFLOXACIN;
LINEZOLID;
MACROLIDE;
MONOCLONAL ANTIBODY;
MOXIFLOXACIN;
ORITAVANCIN;
PENICILLIN DERIVATIVE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RAMOPLANIN;
RETAPAMULIN;
TELAVANCIN;
TIGECYCLINE;
UNCLASSIFIED DRUG;
VACCINE;
VIBATIV;
ANTIINFECTIVE AGENT;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC RESISTANCE;
BACTERIAL INFECTION;
BIOTECHNOLOGY;
COMMUNICABLE DISEASE;
DIABETIC FOOT;
DRUG APPROVAL;
DRUG MARKETING;
DRUG RESEARCH;
DRUG USE;
FOOD AND DRUG ADMINISTRATION;
HOSPITAL INFECTION;
HUMAN;
LABORATORY TEST;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
NONHUMAN;
PATENT;
PRESCRIPTION;
PRIORITY JOURNAL;
RESPIRATORY TRACT INFECTION;
SHORT SURVEY;
SKIN INFECTION;
SOFT TISSUE INFECTION;
TREND STUDY;
UNITED STATES;
URINARY TRACT INFECTION;
COMMERCIAL PHENOMENA;
DRUG DESIGN;
DRUG INDUSTRY;
ECONOMICS;
ANTI-BACTERIAL AGENTS;
COMMERCE;
DRUG DESIGN;
DRUG INDUSTRY;
DRUG RESISTANCE, BACTERIAL;
HUMANS;
|
EID: 77956307436
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3267 Document Type: Short Survey |
Times cited : (233)
|
References (6)
|